KLOW is a compound blend containing four peptides with distinct and complementary research profiles: GHK-Cu, KPV, BPC-157, and TB-500.
GHK-Cu (glycine-L-histidine-lysine copper complex) is a small copper-binding peptide with well-documented activity in wound healing, tissue regeneration, and connective tissue remodeling, including collagen, elastin, and glycosaminoglycan synthesis.
KPV is a naturally occurring tripeptide derived from the C-terminus of alpha-melanocyte stimulating hormone (α-MSH), studied for its anti-inflammatory effects — including inhibition of NF-κB signaling — independent of melanocortin receptor activation.
BPC-157 is a synthetic pentadecapeptide derived from a protein sequence found in human gastric juice, investigated across preclinical models for its roles in vascular signaling, inflammatory modulation, and tissue regeneration — particularly in musculoskeletal and gastrointestinal research contexts. Westlake Dermatology
TB-500 is a research peptide corresponding to the actin-binding domain of Thymosin Beta-4, specifically the amino acid sequence Ac-LKKTETQ (residues 17–23 of the full peptide). It is studied for its roles in cell migration, angiogenesis, and tissue repair. Springer
KLOW is supplied in lyophilized form at 80mg total peptide content for research use.
Format: Lyophilized powder | Purity: ≥98% (LC-MS verified) reconstitute with bacteriostatic water, store at 4°C
For Research Use Only. Not for human or veterinary use. No medical claims are made.
